Akebia Therapeutics, Inc. Share Price
NASDAQ: AKBAHealthcare
Live Akebia Therapeutics, Inc. Share Price Chart
O H L
Akebia Therapeutics, Inc. Performance Overview
Days Range
▼
$0.88Low
$0.91High
Markets Today
| Previous Close | $0.90 |
|---|---|
| Open | $0.89 |
| Volume | 786,076 |
| Day's Range | $0.88 - $0.91 |
| 52W Range | $0.81 - $3.20 |
| Market Cap | $254.33 M |
Historical Performance
| 1M Returns | +5.13 |
|---|---|
| 3M Returns | -16.31 |
| 6M Returns | -37.81 |
| 1Y Returns | -69.75 |
| 5Y Returns | -69.12 |
| 10Y Returns | -90.12 |
Akebia Therapeutics, Inc. Fundamentals
| Market Cap | $254.33 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $236.20 M |
| ROE TTM | N/A |
| EPS TTM | $-0.11 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 9.97 |
| EBITDA | $24.77 M |
| Profit Margin | -2.26 |
| Market Cap | $254.33 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $236.20 M |
| ROE TTM | N/A |
| EPS TTM | $-0.11 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 9.97 |
| EBITDA | $24.77 M |
| Profit Margin | -2.26 |
Akebia Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $57.34 M | $62.47 M | $58.77 M | $57.62 M | $53.54 M | $49.13 M |
| Gross Profit + | $49.71 M | $52.55 M | $49.38 M | $45.09 M | $41.25 M | $38.70 M |
| Operating Income | $13.51 M | $14.09 M | $4.45 M | -$8.55 M | -$4.70 M | -$6.33 M |
| EBITDA | $13.83 M | $14.40 M | $4.77 M | -$8.23 M | -$4.37 M | -$3.80 M |
| Interest Expense | $0 | -$6.83 M | $0 | $0 | $0 | -$3.07 M |
| Depreciation | $314.00 K | $316.00 K | $318.00 K | $321.00 K | $328.00 K | $2.53 M |
| Income Before Tax | $6.11 M | $247.00 K | $1.16 M | -$11.23 M | -$8.93 M | -$8.84 M |
| Income Tax Expense | $0 | $0 | $615.00 K | $1.01 M | $126.00 K | $70.00 K |
| Net Income + | $6.11 M | $247.00 K | $540.00 K | -$12.24 M | -$9.05 M | -$8.91 M |
| Net Profit Margin | 10.66% | 0.4% | 0.92% | -21.25% | -16.91% | -18.13% |
Akebia Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$1.67 B | -$1.67 B | -$1.67 B | -$1.68 B | -$1.69 B | -$1.70 B |
| Non-Current Liabilities | $194.38 M | $197.65 M | $189.18 M | $181.02 M | $161.26 M | $163.78 M |
| Current Liabilities | $91.23 M | $118.72 M | $133.38 M | $162.94 M | $173.88 M | $160.87 M |
| Total Liabilities | $285.60 M | $316.37 M | $322.56 M | $343.95 M | $335.14 M | $324.64 M |
| Fixed Assets | $1.90 M | $1.71 M | $1.47 M | $1.22 M | $956.00 K | $1.51 M |
| Current Assets | $203.78 M | $234.66 M | $258.34 M | $252.96 M | $243.48 M | $229.55 M |
| Total Assets | $310.19 M | $345.60 M | $364.15 M | $376.56 M | $362.52 M | $349.66 M |
Akebia Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $6.11 M | $247.00 K | $540.00 K | -$12.24 M | -$9.05 M | -$8.91 M |
| Operating Cash Flow | -$13.59 M | $22.34 M | $28.11 M | $31.13 M | -$21.21 M | $3.52 M |
| Investing Cash Flow | $154.00 K | -$126.00 K | -$77.00 K | -$7.88 M | -$62.00 K | -$4.08 M |
| Financing Cash Flow | $74.94 M | $1.72 M | $1.11 M | -$4.85 M | -$926.00 K | -$6.54 M |
| Change in Cash | $61.51 M | $23.94 M | $29.14 M | $18.40 M | -$22.20 M | -$7.09 M |
Akebia Therapeutics, Inc. Return Calculator
The Akebia Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,000
Invested Amount$10,000
Est. Returns$-7,000
About Akebia Therapeutics, Inc.
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Popular Stocks
FAQs
What is the share price of Akebia Therapeutics, Inc. today?
Akebia Therapeutics, Inc. (AKBA) share price as of September 18, 2026 is $0.87. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Akebia Therapeutics, Inc.?
Yes, Indian Investors can invest in the Akebia Therapeutics, Inc. (AKBA) Share by opening an international trading account with Angel One.
How can I purchase Akebia Therapeutics, Inc. shares in India?
Purchasing Akebia Therapeutics, Inc. (AKBA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Akebia Therapeutics, Inc. (AKBA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Akebia Therapeutics, Inc.?
Yes, you can purchase fractional shares of Akebia Therapeutics, Inc. (AKBA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Akebia Therapeutics, Inc.?
The market capitalization of Akebia Therapeutics, Inc. on September 18, 2026, is $254.33 M.
In which sector Akebia Therapeutics, Inc. belongs?
Akebia Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Akebia Therapeutics, Inc. stocks?
In order to invest in Akebia Therapeutics, Inc. (AKBA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
